Intractable genital ulcers from herpes simplex virus reactivation in drug-induced hypersensitivity syndrome caused by allopurinol

International Journal of Dermatology

Volumn 49, Issue 6, 2010, Pages 700-704

  Hamaguchi, Yasuhito ^a   Fujimoto, Manabu ^a   Enokido, Yuri ^a   Wayaku, Takamasa ^a   Kaji, Kenzo ^a   Echigo, Takeshi ^a   Takehara, Kazuhiko ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AMLODIPINE BESYLATE; FUROSEMIDE; GANCICLOVIR; METHYLPREDNISOLONE; PREDNISOLONE; SPIRONOLACTONE; VALACICLOVIR; VIDARABINE; ANTIGOUT AGENT;

AGED; ARTICLE; CASE REPORT; CELL DEATH; CELL DEGENERATION; CELL INCLUSION; CONJUNCTIVAL HYPEREMIA; CROSS REACTION; CYTOMEGALOVIRUS; DISEASE EXACERBATION; DRESS SYNDROME; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG ERUPTION; DRUG FEVER; DRUG RESISTANCE; DRUG WITHDRAWAL; EPIDERMIS CELL; GENITAL ULCER; GIANT CELL; HERPES SIMPLEX VIRUS; HUMAN; HUMAN TISSUE; HYPERTENSION; HYPERURICEMIA; KIDNEY DYSFUNCTION; LEUKOCYTOSIS; LYMPHOCYTIC INFILTRATION; MALE; PURPURIC RASH; SKIN BIOPSY; COMPLICATION; DRUG EFFECTS; DRUG HYPERSENSITIVITY; GENITAL HERPES; SKIN ULCER; VERY ELDERLY; VIROLOGY; VIRUS ACTIVATION;

AGED, 80 AND OVER; ALLOPURINOL; DRUG HYPERSENSITIVITY; GOUT SUPPRESSANTS; HERPES GENITALIS; HUMANS; HYPERURICEMIA; MALE; SKIN ULCER; VIRUS ACTIVATION;

EID: 77954185811     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2009.04441.x     Document Type: Article

References (22)

1. Suzuki Y, Inagi R, Aono T. Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermatol 1998, 134:1108-1112.
2. Seishima M, Yamanaka S, Fujisawa T. Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome. Br J Dermatol 2006, 155:344-349.
3. Descamps V, Bouscarat F, Laglenne S. Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome. Br J Dermatol 1997, 137:605-608.
4. Kano Y, Hiraharas K, Sakuma K, Shiohara T. Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease. Br J Dermatol 2006, 155:301-306.
5. Descamps V, Mahe E, Houhou N. Drug-induced hypersensitivity syndrome associated with Epstein-Barr virus infection. Br J Dermatol 2003, 148:1032-1034.
6. Aihara M, Sugita Y, Takahashi S. Anticonvulsant hypersensitivity syndrome associated with reactivation of cytomegalovirus. Br J Dermatol 2001, 144:1231-1234.
7. Mitani N, Aihara M, Yamakawa Y. Drug-induced hypersensitivity syndrome due to cyanamide associated with multiple reactivation of human herpesviruses. J Med Virol 2005, 75:430-434.
8. Khanna KM, Lepisto AJ, Decman V, Hendricks RL. Immune control of herpes simplex virus during latency. Curr Opin Immunol 2004, 16:463-469.
9. Reinke P, Prosch S, Kern F, Volk HD. Mechanisms of human cytomegalovirus (HCMV) (re)activation and its impact on organ transplant patients. Transpl Infect Dis 1999, 1:157-164.
10. Shiohara T, Kano Y. A complex interaction between drug allergy and viral infection. Clin Rev Allergy Immunol 2007, 33:124-133.
11. Grefte JM, van der Gun BT, Schmolke S. The lower matrix protein pp65 is the principal viral antigen present in peripheral blood leukocytes during an active cytomegalovirus infection. J Gen Virol 1992, 73:2923-2932.
12. Bernabeu-Wittel M, Pachon-Ibanez J, Cisneros JM. Quantitative pp65 antigenemia in the diagnosis of cytomegalovirus disease: prospective assessment in a cohort of solid organ transplant recipients. J Infect 2005, 51:188-194.
13. McInnes GT, Lawson DH, Jick H. Acute adverse reactions attributed to allopurinol in hospitalised patients. Ann Rheum Dis 1981, 40:245-249.
14. Markel A. Allopurinol-induced DRESS syndrome. Isr Med Assoc J 2005, 7:656-660.
15. Kato C, Sato K, Wakabayashi A, Eishi Y. The effects of allopurinol on immune function in normal BALB/c and SCID mice. Int J Immunopharmacol 2000, 22:547-556.
16. Kano Y, Inaoka M, Shiohara T. Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia. Arch Dermatol 2004, 140:183-188.
17. Blanca IR, Bere EW, Young HA, Ortaldo JR. Human B cell activation by autologous NK cells is regulated by CD40-CD40 ligand interaction: role of memory B cells and CD5+ B cells. J Immunol 2001, 167:6132-6139.
18. Takahashi R, Kano Y, Yamazaki Y. Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome. J Immunol 2009, 182:8071-8079.
19. Ludwig-Portugall I, Hamilton-Williams EE, Gottschalk C, Kurts C. Cutting edge: CD25+ regulatory T cells prevent expansion and induce apoptosis of B cells specific for tissue autoantigens. J Immunol 2008, 181:4447-4451.
20. Fields KS, Petersen MJ, Chiao E, Tristani-Firouzi P. Case reports: treatment of nevirapine-associated dress syndrome with intravenous immune globulin (IVIG). J Drugs Dermatol 2005, 4:510-513.
21. Santos RP, Ramilo O, Barton T. Nevirapine-associated rash with eosinophilia and systemic symptoms in a child with human immunodeficiency virus infection. Pediatr Infect Dis J 2007, 26:1053-1056.
22. Kano Y, Inaoka M, Sakuma K, Shiohara T. Virus reactivation and intravenous immunoglobulin (IVIG) therapy of drug-induced hypersensitivity syndrome. Toxicology 2005, 209:165-167.